Clinical Trial Update: Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999 [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating a new radiopharmaceutical, [18F] LBT-999, to quantify the dopamine transporter in humans with Parkinson's disease has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• [18F] LBT-999 (LBT-999)

Snippet

Sponsor: University Hospital, Tours | Conditions: Idiopathic Parkinson Disease | EARLY_Phase 1 | Status: TERMINATED